Chemistry: analytical and immunological testing – Involving an insoluble carrier for immobilizing immunochemicals – Carrier is inorganic
Reexamination Certificate
2005-06-30
2010-02-02
Chin, Christopher L (Department: 1641)
Chemistry: analytical and immunological testing
Involving an insoluble carrier for immobilizing immunochemicals
Carrier is inorganic
C436S512000, C436S525000, C436S064000
Reexamination Certificate
active
07655479
ABSTRACT:
Luminescent semiconductor quantum dots (QDs) conjugated with biomolecules to serve as sensitive probes for early detection of the cancer cells, specifically for ovarian cancer and lung cancer, which represents the most lethal malignancies. The luminescence characterization of the bin-conjugated QDs with cancer specific antigens using linkage molecules. Photo-enhancement is measured at various laser density power, temperatures and laser wavelengths.
REFERENCES:
patent: 5320956 (1994-06-01), Willingham et al.
patent: 6306610 (2001-10-01), Bawendi et al.
patent: 6423551 (2002-07-01), Weiss et al.
patent: 2004/0023415 (2004-02-01), Sololov et al.
Margaret A. Hines and Philippe Guyot-Sionnest, Synthesis and Characterization of Strongly Luminescing ZnS-Capped CdSe Nanocrystals,J. Phys, Chem. 1996, 100, p. 468-471.
Marcel Bruchez et al., Semiconductor Nanocrystals as Fluorescent Biological Labels, Science, vol. 281, 1998.
Ellen R. Goldman, Avidin: A Natural Bridge for Quantum Dot-Antibody Conjugates, J. Am. Chem. Soc., 2002, 124, p. 6378-6382.
B.O. Dabbousi et al., (CdSe) ZnS Core-Shell Quantum Dots: Synthesis and Characterization of a Size Series of Highly Luminescent Nanocrystallites, J. Phsy. Chem., 1997, 101, p. 9463-9475.
J. Rodriguez-Viejo, Evidence of Photo-and Electrodarkening of (CdSe) ZnS Quantum Dot Composites, Journal of Applied Physcs, vol. 87, No. 12, 2000.
N.E. Korsunskaya et al., Photochemical Reactions at Low Temperatures in CdS Single Crystals, Phys. Stat. Sol., 13, p. 25-36, 1966.
Maria E. Akerman, Nanocrystal Targeting In Vivo, Proc. Nat'l Acad. Sci., vol. 99, No. 20, p. 12617-12621, 2002.
M.K. Sheinkman, The Recharge-Enhance Transformations of Donor-Acceptor Pairs and Clusters in CdS, J. Phys. Chem. Solids, vol. 43. No. 5, p. 475-479, 1982.
N.E. Korsunskaya et al., The Influence of Carrier Trapping on Defect Reaction Activation Energy in Semiconductors (Pesudo-Effect of Recombination Enhanced Diffusion), J. Phys. Chem. Solids, vol. 53, No. 3, p. 469-474, 1992.
C.A. Leatherdale, Photoconductivity in CdSe Quantum Dot Solids, The American Physical Society, vol. 62, No. 4, p. 26692680, 2000.
N.E. Korsunskaya et al., Photosensitivity Degradation Mechanism in CdS: Cu Single Crystals, Phys. Stat. Sol., vol. 60, p. 565-572, 1980.
Xingyong Wu et al., Immunofluorescent Labeling of Cancer Marker Her2 and Other Cellular Targets With Semiconductor Quantum Dots, Nature Biotechnology, vol. 21, p. 41-46, 2003.
Benoit Debertret, In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles, Science, vol. 298, p. 1759-1762, 2002.
Juoti K. Jaiswal, Long-Term Multiple Color Imaging of Live Cells Using Quantum Dot Bioconjugates, Nature Biotechnology, vol. 21, p. 47-51, 2003.
A. Gartagdyev, Mechanism of Photostimulated Dissociation of Donor-Acceptor Pairs in CdS Crystals and in CdSxSe1-x Solid Soultion, American Institute of Physics, vol. 21, No. 3, p. 249-251, 1987.
D.I. Chepic, Auger Ionization of Semiconductor Quantum Drops in a Glass Matrix, Journal of Luminescence 47, p. 113-127, 1990.
Abbate I, et al. Tumor necrosis factor and soluble interleukin-2 receptor: Two immunological biomarkers in female neoplasm. Eur J Gynaecol Oncol 13(1 Suppl} p. 92-6, 1992.
Bergkessel M, Reese JC. An essential role for theSaccharomyces cerevisiaeDEAD-box helicase DHH1 in G1/S DNA-damage checkpoint recovery. Genetics. May 2004;167(1}:21-33.
Berse B, Brown LF, Van De Water L, Dvorak HF, Senger DR Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell: 3(2) 211-20, 1992.
Campa MJ, et al. Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer. Cancer Res 63:1652-1656, 2003.
De Bruijn HW, Ten Hoor KA, Van Der Zee AG. Serum and cystic fluid levels of soluble iterleukin-2 receptor-alpha in patients with epithelial ovarian tumors are correlated. Tumour 1998, 19(3) p. 160-6.
Endoh H. Tomida S Yatahe Y. Konishi H, Osada H, Tajima K, Kuwano H, Takahashi T, Mitsudom! T, Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction J Clin Oncol. Mar. 1, 2004;22(5):811-9.
Gadducci A, et al. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer Gynecol Oncol, 52(3). p. 386-91 1994.
Gendler SJ, Spicer AP. Epithelial mucin genes Annu Rev Physiol 57: p. 607-34. 1995.
Geng Z. Zhang D, Liu Y. Expression of telomerase hTERT in human non-small cell lung cancer and its correlation with c-myc gene. Chinese Medical J. 116(10):1467-1470.2003.
Hara T. Ishida H. Raziuddin R, Dorkhom S, Kamijo K, Miki T., Mol Biol Cell Mar. 15, 2004(3}:1172-84. Epub Dec. 10, 2003.
Hsu CP, Miaw J, Hsia JY, Shai SE, Chen CY, Concordant expression of the telomerase-associated genes in non-small cell lung cancer. Europ J of Surgical Oncology, 29(7):594-599, 2003.
Hurteau JA, Simon UH, Kurman C, Rubin L, Mills, GB, Levels of soluble interleukin-2 receptor-alpha are elevated in serum and ascitic fluid from epithelial ovarian cancer patients, Am J Obstet Gynecol 170(3) p. 918-28., 1994.
Hurteau JA, Woolas RP, Jacobs IJ, Oram DC, Kurman CC, Rubin LA, Nelson DL, Berchuck A, Bast RC Jr, Mills GB. Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer. Cancer, 1995. 76(9) p. 1615-20.
Jang SJ, Soria JC, Wang L, et al. Activation of melanoma tumor antigens occurs early in lung carcinogenesis Cancer Res 61: 7959-7963, 2001.
Lagarde A, Forgach T, Nagy D, Nagy K, Vasas S, Janoki GA. Diagnostic sensitivity of three tumour markers in non-small cell lung cancer: a pilot study. Nucl Med Rev Cent East Eur:3(2): 139-42 2000.
Lantuejoul S, et al. Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours Br J Cancer. Mar. 22,90(6)1222-9.2004.
Lendeckel U, Kohl J, Arndt M, Carl-McGrath S. Donat H, Rocken C. Increased expression of ADAM family members in human breast cancer and breast cancer cell lines. J Cancer Res Clin Oncol. 2005, 131(1):41-8.
Mecklenburg I, et al. Detection of melanoma antigen-A expression in sputum and bronchial lavage fluid of patients with lung cancer. Chest 125 S)164$-1 2004.
Mimnaugh EG, et al. Prevention of cisplatin-DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitors Biochem Pharmacol. Nov. 1, 2000 ;60(9): 1343-54.
Neufeld G, Tessler S, Gitay-Goren H, Cohen T, Levi BZ, Vascular endothelial growth factor and its receptors. Prog Growth Factor Res 5(1): 89-97, 1994.
Payne M, Yang Z, Katz SJ, Warner JE, Weight CJ. Zhao Y, Pearson ED, Treft RL, Hillman T, Kennedy RJ, Meire FM. Zhang K. Am J Ophthalmol Nov. 2004;138(5) 749-55.
Powell BL, Toomes C, Scott S, Yeung A, Marchbank NJ, Spry PG, Lumb R, Inglehearn CF, Churchill AJ. Mol Vis Sep. 22, 2003:9:460-4.
Schmoll HJ, et al. European consensus on diagnosis and treatment of germ cell cancer a report of the European Germ Cell Cancer Consensus Group (EGCCCG) Ann Oncol Sep. 15, 2004:1377.99.
Sedlaczek P, et al. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma. Cancer, 2002 95(9) p. 1886-93.
Senger DR, et al. The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell and tumor angiogenesis. Am J Pathol, 2002. 160(1):195-204.
Song L, Turkson J, Karras JG, Jove R, Haura EB. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Oncogene 22(27):4150-65, 2003.
Sozzi G, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J of Clin Oncol, 21 (21):3902-3908, 2003.
Sugita M, et al. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as
Lancaster Johnathan
Ostapenko Sergei
Sellers Thomas A.
Sutphen Rebecca
Zhang Jin Z.
Chin Christopher L
H. Lee Moffitt Cancer Center and Research Institute, Inc.
Smith & Hopen , P.A.
The Regents of the University of California
University of South Florida
LandOfFree
Luminescence characterization of quantum dots conjugated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Luminescence characterization of quantum dots conjugated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Luminescence characterization of quantum dots conjugated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4199216